enGene Therapeutics (ENGN) Shares Outstanding (2022 - 2026)
enGene Therapeutics (ENGN) posted Shares Outstanding of 69.73 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 36.5% from 51.1 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Shares Outstanding (2022 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics' Shares Outstanding came in at 51.12 million, up 35.3% from FY2024.
- Annual Shares Outstanding shows a three-year compound annual growth rate of 327.3% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Shares Outstanding was 37.78 million in FY2024, 692,609 in FY2023 (+5.7%) and 655,153 in FY2022.
- The fiscal Q3 2026 figure stands as the highest quarterly Shares Outstanding in data going back to fiscal Q4 2022.
- On a year-over-year basis, Shares Outstanding has increased in each of the last seven quarters, with growth averaging 43.6% over the last seven quarters.
- The year-over-year growth in Shares Outstanding has ranged between 5.7% (fiscal Q4 2023) and 119.7% (fiscal Q1 2025) over the last five years.
- According to Business Quant data, Shares Outstanding for the three prior fiscal quarters was 69.72 million (Q2 2026), 67.26 million (Q1 2026) and 51.12 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.70 Bn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 69.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 69.73 Mn |
| Apr 30, 2026 | 69.72 Mn |
| Jan 31, 2026 | 67.26 Mn |
| Oct 31, 2025 | 51.12 Mn |
| Jul 31, 2025 | 51.10 Mn |
| Apr 30, 2025 | 51.02 Mn |
| Jan 31, 2025 | 50.98 Mn |
| Oct 31, 2024 | 37.78 Mn |
| Jul 31, 2024 | 44.17 Mn |
| Apr 30, 2024 | 39.44 Mn |
| Jan 31, 2024 | 23.20 Mn |
| Oct 31, 2023 | 692,609.00 |
| Jul 31, 2023 | 701,323.00 |
| Apr 30, 2023 | 694,497.00 |
| Jan 31, 2023 | 651,074.00 |
| Oct 31, 2022 | 655,153.00 |
API Access
enGene Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();